Estrella Immunopharma appoints Jia Dengyao to Board of Directors

Estrella Immunopharma, Inc.

Board appointed Jia Dengyao as director effective September 22, 2025.
Mr. Jia has not been named to any Board committees as of the filing.
Company entered into standard indemnification agreement with new director.
Appointment adds a new independent voice but no other details provided.

item 5.02

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.